FDA.reportPublic FDA data

Application 084840

Type
ANDA
Sponsor
LANNETT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ACETAZOLAMIDEACETAZOLAMIDETABLET;ORAL250MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0527-1050AcetaZOLAMIDEAcetazolamideLannett Company, Inc.ANDACurrent
0527-1050AcetaZOLAMIDEAcetazolamideLannett Company, Inc.ANDACurrent
0527-1050AcetaZOLAMIDEAcetazolamideLannett Company, Inc.ANDACurrent
0527-1050AcetaZOLAMIDEAcetazolamideLannett Company, Inc.ANDACurrent
10135-567AcetaZOLAMIDEAcetazolamideMarlex Pharmaceuticals IncANDACurrent
10135-567AcetaZOLAMIDEAcetazolamideMarlex Pharmaceuticals IncANDACurrent
42291-103AcetaZOLAMIDEAcetazolamideAvKARE, Inc.ANDACurrent
42291-103AcetaZOLAMIDEAcetazolamideAvKARE, Inc.ANDACurrent
42291-103AcetaZOLAMIDEAcetazolamideAvKAREANDACurrent
50090-3003AcetaZOLAMIDEAcetazolamideA-S Medication SolutionsANDACurrent
50090-3003AcetaZOLAMIDEAcetazolamideA-S Medication SolutionsANDACurrent
50090-3003AcetaZOLAMIDEAcetazolamideA-S Medication SolutionsANDACurrent
67296-0801AcetaZOLAMIDEAcetazolamideRedPharm Drug Inc.ANDACurrent
68084-541AcetaZOLAMIDEAcetazolamideAmerican Health PackagingANDACurrent
68084-541AcetaZOLAMIDEAcetazolamideAmerican Health PackagingANDACurrent
68084-541AcetaZOLAMIDEAcetazolamideAmerican Health PackagingANDACurrent